BARR FDA Friday, April 25, 2003 +0.20 Positive

FDA Approves Unknown Drug — BARR

The FDA has approved Barr Laboratories' NDA for Zoloft, a widely used antidepressant, marking a potential restocking opportunity for the company amidst a challenging pricing environment for anti-psychotic therapies.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed